A slow heartbeat, medically known as bradycardia, occurs when the heart beats fewer than 60 times per minute at rest. This condition may result from electrical signal disruptions in the heart's conduction system, underlying health issues, or medication side effects. Not all cases require treatment, but persistent bradycardia can lead to fatigue, dizziness, or fainting.
Bradycardia arises when the sinus node-the heart's natural pacemaker-fails to generate impulses at a normal rate, or when signals are blocked between the atria and ventricles. The most common causes include age-related changes, certain medications, heart disease, and metabolic disorders. Some individuals, especially trained athletes, maintain low resting heart rates without symptoms or complications.
For example, a 72-year-old man with a history of hypertension began experiencing episodes of lightheadedness. His resting heart rate was recorded at 44 bpm during a routine visit. Further testing revealed sick sinus syndrome, a disorder where the sinus node doesn't fire properly. After implantation of a permanent pacemaker, his symptoms resolved completely.
The heart's rhythm begins in the sinoatrial (SA) node, located in the right atrium. Electrical impulses travel through the atria, pause briefly at the atrioventricular (AV) node, then move into the ventricles. A delay or failure at any stage can reduce heart rate.
When the SA node fires too slowly, the heart rate drops. This can happen due to fibrosis or scarring in the node tissue, often seen in older adults. AV block occurs when signals from the atria fail to reach the ventricles. First-degree AV block involves delayed conduction; second- and third-degree blocks involve partial or complete signal failure, respectively.
Electrolyte imbalances such as high potassium or low calcium disrupt ion flow across cardiac cell membranes. These changes interfere with the timing and strength of electrical impulses. For instance, a patient with chronic kidney disease developed bradycardia after serum potassium rose to 6.8 mmol/L-a level that suppresses cardiac excitability.
Heart disease is the leading cause of symptomatic bradycardia. Coronary artery disease can damage the conduction system, particularly if a prior heart attack affected the left anterior descending artery. Studies show that up to 15% of patients with acute myocardial infarction develop significant bradycardia during the first 24 hours.
Other conditions include hypothyroidism, where low thyroid hormone levels slow metabolism and reduce heart rate. A 2021 study published in *The Journal of Clinical Endocrinology & Metabolism* found that untreated hypothyroidism led to a mean heart rate reduction of 12 beats per minute compared to euthyroid controls.
Autoimmune disorders such as lupus or Sjögren's syndrome can infiltrate the heart's conduction pathways. In one case report, a woman with Sjögren's syndrome developed complete heart block requiring pacemaker insertion after six months of progressive fatigue and syncope.
| Condition | Typical Heart Rate Range | Key Mechanism |
|---|---|---|
| Sick Sinus Syndrome | 30-50 bpm | SA node dysfunction |
| Complete AV Block | 30-40 bpm | Signal fails from atria to ventricles |
| Hypothyroidism | 40-60 bpm | Reduced metabolic demand |
| Medication-induced | 40-60 bpm | β-blockers, calcium channel blockers |
Several commonly prescribed drugs affect heart rate. Beta-blockers such as metoprolol and atenolol reduce sympathetic nervous system activity, lowering heart rate. They're used for hypertension, angina, and post-heart attack recovery. In clinical trials, up to 20% of patients on beta-blockers experienced heart rates below 60 bpm.
Calcium channel blockers like diltiazem and verapamil also slow conduction through the AV node. These are frequently used for arrhythmias and blood pressure control. A 2019 analysis in *Circulation* showed that 14% of patients on long-term verapamil had bradycardia requiring dose adjustment.
Antiarrhythmic agents such as amiodarone and digoxin carry a higher risk. Digoxin increases vagal tone and slows AV nodal conduction. In older adults, even therapeutic doses can produce heart rates below 50 bpm. One case series reported five patients who developed symptomatic bradycardia within two weeks of starting digoxin therapy.
Many assume that a low heart rate always indicates a problem. This is incorrect. Athletes and people with high cardiovascular fitness often have resting heart rates between 40 and 60 bpm without symptoms. A 2020 review in *European Heart Journal* noted that elite endurance athletes routinely exhibit bradycardia as a sign of efficient cardiac function.
Another misconception is that bradycardia always causes symptoms. In reality, many individuals with heart rates below 50 bpm remain asymptomatic. A large cohort study found that only 38% of patients with documented bradycardia reported fatigue or dizziness, and only 12% required intervention.
I once evaluated a 35-year-old marathon runner whose resting heart rate was 42 bpm. He reported no dizziness, chest pain, or exercise intolerance. An echocardiogram showed normal systolic function and no structural abnormalities. No treatment was needed-he simply continued training safely.
Seek evaluation if bradycardia is accompanied by dizziness, confusion, shortness of breath, chest pain, or fainting. These signs suggest inadequate blood flow to important organs. A heart rate consistently below 50 bpm with symptoms warrants urgent assessment.
Diagnostic tools include electrocardiograms (ECGs), Holter monitors (24-hour recordings), and event recorders for intermittent symptoms. Electrophysiology studies may be used in complex cases to map conduction pathways.
If you're managing a condition that affects heart rate, such as heart failure or diabetes, regular monitoring is essential. For example, a patient with type 2 diabetes on metformin and a beta-blocker should have annual ECGs to detect early conduction changes.